FOLH1 and prostate carcinoma: To determine whether prostate cancer cells were detectable in urine prior to DRE, voided urine specimen collected from 31 patients (Table 1) without prior DRE were tested for GAPDH, KLK3, AR, PCA3, and PSMA via qRT-PCR.